Search results for

President Obama met with tech leaders Tuesday at the White House. The subject was the troubled Affordable Care Act website and the challenges of federal procurement. The president also tapped one of their own to take over the overhaul of HealthCare.gov: Kurt DelBene, a former Microsoft executive and husband of Rep. Suzan DelBene.

A federal appeals court rules that Vice President Cheney does not have to disclose who advised him as he created the Bush administration's energy policy. Journalists and interest groups had sued to find out which energy industry executives had been involved. Lawyer Shannen Coffin, who argued Cheney's case in district court, discusses the decision.

The White House says President Biden will try to answer the Supreme Court's reversal of Roe v. Wade, and preserve access to abortion services by signing an executive order on reproductive rights.

After a probe that lasted over a year, the House panel investigating the Jan. 6 U.S. Capitol attack is winding down with the release of its full report, seen as one of its final duties.

Brazil's new leader Luiz Inácio Lula da Silva meets Friday with President Biden. The two presidents have a lot in common — both Brazil and the U.S. suffered attacks by right-wing extremists.

After fifteen rounds of voting, House Republicans finally got Kevin McCarthy as their House Speaker. We look at what that means moving forward, in taking on the work that Congress must undertake.

The 800-page report details why the panel recommended four criminal referrals against former President Donald Trump. The report comes after the panel's final business hearing on Monday.

We break down the messaging in President Biden's latest budget proposal, a document that the White House is using to try to pressure Republicans in Congress ahead of the looming debt limit deadline.

Pressured by demanding global financial markets and a populist backlash at home, President Obama unloaded on AIG executives Monday for keeping bonuses but extended an offer of help to small businesses.

To lower drug prices, the Biden administration is looking to assert its authority to license drug patents that rely on government-funded research to drugmakers that would offer cheaper medicines.